RU2012136622A - MEDICINES ON THE BASIS OF TETRAMETHYL TETRAAZOBICYCLOOCTANDION AND THE METHOD FOR ITS PRODUCTION - Google Patents
MEDICINES ON THE BASIS OF TETRAMETHYL TETRAAZOBICYCLOOCTANDION AND THE METHOD FOR ITS PRODUCTION Download PDFInfo
- Publication number
- RU2012136622A RU2012136622A RU2012136622/15A RU2012136622A RU2012136622A RU 2012136622 A RU2012136622 A RU 2012136622A RU 2012136622/15 A RU2012136622/15 A RU 2012136622/15A RU 2012136622 A RU2012136622 A RU 2012136622A RU 2012136622 A RU2012136622 A RU 2012136622A
- Authority
- RU
- Russia
- Prior art keywords
- drug according
- substance
- granulating agent
- minutes
- corrective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Лекарственное средство, содержащее тетраметилтетраазобициклооктандион, отличающееся тем, что дополнительно содержит наполнитель, гранулирующий агент, скользящее вещество, дезинтегранты, корригирующие вещества при следующем их соотношении, мас.%:2. Лекарственное средство по п.1, отличающееся тем, что в качестве наполнителей используется по крайней мере одно из следующих веществ: микрокристаллическая целлюлоза, лактозы моногидрат, кальция фосфат основной, маннитол, глюкоза, крахмал картофельный, крахмал кукурузный, причем перечень не ограничивается.3. Лекарственное средство по п.1, отличающееся тем, что в качестве гранулирующего агента используется любой фармацевтически приемлемый гранулирующий агент, в том числе 2,47% раствор поливинилпирролидона или 5% крахмальный клейстер.4. Лекарственное средство по п.1, отличающееся тем, что в качестве скользящих веществ используется по крайней мере одно из следующих веществ, выбранное из производных стеариновой кислоты: кальция стеарат, магния стеарат, натрия стеарилфумарат или кремния диоксид коллоидный (аэросил), причем перечень не ограничивается..5. Лекарственное средство по п.1, отличающееся тем, что в качестве дезинтегранта используют карбоксиметилкрахмал (примогель) или кроскармелозу натрия (примеллоза).6. Лекарственное средство по п.1, отличающееся тем, что в качестве корригирующего вещества используют по крайней мере одно из следующих веществ: фруктоза, мальтоза, лактоза, инвертный сахар, лимонная кислота, глицерин, сахарол, дульцин, сахарин, сорбитол, а также искусственные подсластители цикломаты (натриевая и кальциевая соли циклогексилсульфаминовой кислоты); 1. A medicine containing tetramethyltetraazobicyclooctanedione, characterized in that it further comprises a filler, granulating agent, a moving substance, disintegrants, corrective substances in the following ratio, wt.%: 2. The medicine according to claim 1, characterized in that at least one of the following substances is used as fillers: microcrystalline cellulose, lactose monohydrate, basic calcium phosphate, mannitol, glucose, potato starch, corn starch, and the list is not limited. The medicine according to claim 1, characterized in that any pharmaceutically acceptable granulating agent is used as the granulating agent, including a 2.47% solution of polyvinylpyrrolidone or 5% starch paste. The medicament according to claim 1, characterized in that at least one of the following substances selected from stearic acid derivatives is used as glidants: calcium stearate, magnesium stearate, sodium stearyl fumarate or silicon colloidal dioxide (aerosil), and the list is not limited ..5. The medicine according to claim 1, characterized in that carboxymethyl starch (primogel) or croscarmellose sodium (primellose) are used as a disintegrant. The medicine according to claim 1, characterized in that at least one of the following substances is used as a corrective substance: fructose, maltose, lactose, invert sugar, citric acid, glycerin, sugar, dulcin, saccharin, sorbitol, as well as artificial sweeteners cyclomats (sodium and calcium salts of cyclohexyl sulfamic acid);
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012136622A RU2611194C2 (en) | 2012-08-27 | 2012-08-27 | Drug based on tetrametiltetraazobitsiklooktandion and method for its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012136622A RU2611194C2 (en) | 2012-08-27 | 2012-08-27 | Drug based on tetrametiltetraazobitsiklooktandion and method for its production |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2015113991/15A Division RU2589502C1 (en) | 2015-04-15 | 2015-04-15 | Therapeutic agent and methods for production thereof (versions) |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012136622A true RU2012136622A (en) | 2014-03-10 |
RU2611194C2 RU2611194C2 (en) | 2017-02-21 |
Family
ID=50191263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012136622A RU2611194C2 (en) | 2012-08-27 | 2012-08-27 | Drug based on tetrametiltetraazobitsiklooktandion and method for its production |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2611194C2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2576240C1 (en) * | 2015-02-11 | 2016-02-27 | Открытое Акционерное Общество "Татхимфармпрепараты" | Pharmaceutical composition comprising combination of glycine and tetramethyltetraazabicyclooctandione (version) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110070305A1 (en) * | 2009-09-24 | 2011-03-24 | Alpharx Inc. | Sustained release pharmaceutical composition containing mebicar |
-
2012
- 2012-08-27 RU RU2012136622A patent/RU2611194C2/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2576240C1 (en) * | 2015-02-11 | 2016-02-27 | Открытое Акционерное Общество "Татхимфармпрепараты" | Pharmaceutical composition comprising combination of glycine and tetramethyltetraazabicyclooctandione (version) |
Also Published As
Publication number | Publication date |
---|---|
RU2611194C2 (en) | 2017-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5209966B2 (en) | Method for producing pharmaceutical composition with improved disintegration | |
KR20130076015A (en) | Highly robust fast disintegrating tablet and process for manufacturing the same | |
JP6301934B2 (en) | Solid oral pharmaceutical formulation containing ticagrelor | |
CN104244930A (en) | Orally disintegrating tablet and method for producing same | |
JP6168673B2 (en) | Arylalkylamine compound-containing pharmaceutical composition | |
KR101686033B1 (en) | A pharmaceutical composition comprising immediate-release parts and enteric coated controlled-release pellets containing tamsulosin or its pharmaceutical acceptable salts as an active ingredient | |
JP2017048174A (en) | Orally disintegrable tablet containing chemically stable coated particles containing drug substance | |
JP5823592B2 (en) | Formulation with improved stability | |
JP2010202579A (en) | Acarbose-containing disintegrating preparation in oral cavity | |
RU2012136622A (en) | MEDICINES ON THE BASIS OF TETRAMETHYL TETRAAZOBICYCLOOCTANDION AND THE METHOD FOR ITS PRODUCTION | |
WO2011093828A2 (en) | Solid dosage forms comprising cefprozil | |
WO2013077824A1 (en) | Preparation process for a formulation comprising metformin | |
RU2012124704A (en) | MEDICINES BASED ON DRY EXTRACTS OF MEDICINAL PLANTS AND METHOD FOR PRODUCING IT (OPTIONS) | |
KR101494180B1 (en) | Fast disintegrating tablet suitable for environmentally sensitive drug and process for manufacturing the same | |
WO2017170763A1 (en) | Disintegrable tablet and method for manufacturing same | |
JP7322474B2 (en) | Tablets containing azilsartan | |
ES2373492T3 (en) | PHARMACEUTICAL COMPOSITION WITH ATORVASTATIN ACTIVE INGREDIENT. | |
WO2017061621A1 (en) | Pharmaceutical composition containing aryl alkyl amine compound | |
WO2013077825A1 (en) | Preparation process for a formulation comprising metformin | |
WO2012120522A1 (en) | A taste masked chewable tablet of sildenafil | |
JP2018065752A (en) | Silodosin-containing pharmaceutical composition and method for producing the same | |
JP2012180280A (en) | Solid preparation having improved storage stability | |
KR101593911B1 (en) | Highly robust fast disintegrating tablet and process for manufacturing the same | |
CN104000821B (en) | Oral double-layer tablet containing telmisartan and amlodipine besylate and preparation method thereof | |
RU2006105104A (en) | A MEDICINAL PREPARED WITH AN ANALGESIC, ANTI-DIPLINKING AND PSYCHO-STIMULATING ACTION, AND METHOD FOR PRODUCING IT |